This week’s headlines, plus keynote from Fetch Kansas City Temple Grandin, PhD, MS

Happy Friday! Everyone here at dvm360® hopes you had a fantastic and safe holiday weekend, whether it’s hanging out with your pets or getting out and partying. As you got back to the heart of the matter during this work week, we continued to bring you the latest news in veterinary medicine.

Here’s what was trending this week on dvm360.com:

  • In an interview, Temple Grandin, PhD, MS, explained the inspiration behind his upcoming keynote at next month’s Fetch dvm360® conference in Kansas City, Missouri.
  • The North American veterinary community has announced that in honor of 40 years of the Veterinary Meeting & Expo (VMX), the organization will offer attendees admission to the event at the same price as the original VMX .
  • Dechra’s alpha-2 combination drug for sedation and pain relief in dogs is now available for use as a sedative and pain reliever to aid in clinical exams, procedures and minor surgery.
  • In this recent episode of The Vet Blast podcast, Cathy Meeks, MS, DVM, DACVIM, discusses how drug resistance and better diagnostics may be contributing to the rise in gastrointestinal parasites in fecal tests.
  • The American Veterinary Medical Association revealed this week that the US National List of Notifiable Animal Diseases is expected to be released later this year, having originally been compiled in March 2020.
  • And more!

Did you know we’re heading to Kansas City August 26-28 for our annual Fetch dvm360® Kansas City conference? Early bird registration ends July 11, 2022, so register here today to save!

About Hector Hedgepeth

Check Also

Global Flavored Veterinary Drugs Market SWOT Analysis, Investment, Future Growth and Top Key Players 2022 to 2028 – Shanghaiist

Research on the Global Flavored Veterinary Drugs Market by MarketsandResearch.biz Examines previous and current growth …